ROIV

#569
Roivant Sciences Ltd. - Common Shares
30.2 7 USD
+1.31%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
30.13
30.28
Range Annuel
0.29
32.79
Changement quotidien
+1.31%
Changement Mensuel
+8.53%
Evolution sur 6 mois
+47.80%
Changement Annuel
+65.32%
Clôture Précédente
29.8 8
Open
30.1 7
Low
30.1 3
High
30.2 8
Volume
1 090
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 21.77 B
  • Employee 750
  • Founded 2014
  • CEO Matt Gline
  • Website www.roivant.com
  • Headquarter Bermuda
  • FIGI N/A
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-51.3
ratio cours/chiffre d'affaires
2 326.88

Roivant Sciences Ltd. - Common Shares

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

Nouvelles